The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACADIA PHARMACEUTICALS INC COM 004225108 2,313 72,723 SH   SOLE   72,723 0 0
ALEXION PHARMACEUTICALS INC COM 015351109 760 6,199 SH   SOLE   6,199 0 0
ARATANA THERAPEUTICS INC COM 03874P101 2,045 218,515 SH   SOLE   218,515 0 0
BIOGEN INC COM 09062X103 814 2,600 SH   SOLE   2,600 0 0
DEXCOM INC COM 252131107 1,245 14,200 SH   SOLE   14,200 0 0
EDWARDS LIFESCIENCES CORP COM 28176E108 4,173 34,611 SH   SOLE   34,611 0 0
JOHNSON & JOHNSON COM 478160104 1,536 13,000 SH   SOLE   13,000 0 0
LILLY ELI & CO COM 532457108 1,068 13,310 SH   SOLE   13,310 0 0
REGENERON PHARMACEUTICALS COM 75886F107 201 500 SH   SOLE   500 0 0
TESARO INC COM 881569107 1,002 10,000 SH   SOLE   10,000 0 0
ZOETIS INC CL A 98978V103 827 15,900 SH   SOLE   15,900 0 0